Agenus
AGEN
#8233
Rank
A$0.48 B
Marketcap
A$10.82
Share price
4.47%
Change (1 day)
67.00%
Change (1 year)

P/E ratio for Agenus (AGEN)

P/E ratio as of November 2026 (TTM): 3.54

According to Agenus 's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 3.5396. At the end of 2022 the company had a P/E ratio of -2.98.

P/E ratio history for Agenus from 2001 to 2023

PE ratio at the end of each year

Year P/E ratio Change
2022-2.98-83.02%
2021-17.6490.67%
2020-2.97-41.21%
2019-5.06216.04%
2018-1.60-38.99%
2017-2.62-4.66%
2016-2.75-29.01%
2015-3.87-32.38%
2014-5.73154.32%
2013-2.25-72.56%
2012-8.21406.22%
2011-1.62-61.54%
2010-4.22168.62%
2009-1.5766.67%
2008-0.9421-61.88%
2007-2.4758.27%
2006-1.56-45.17%
2005-2.85-63.58%
2004-7.8219.46%
2003-6.5511.39%
2002-5.88-5.79%
2001-6.24

P/E ratio for similar companies or competitors

Company P/E ratio P/E ratio differencediff. Country
Johnson & Johnson
JNJ
41.3 1,067.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
148 4,075.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
13.7 288.40%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
17.5 394.17%๐Ÿ‡ฌ๐Ÿ‡ง UK
Celldex Therapeutics
CLDX
-6.87-294.00%๐Ÿ‡บ๐Ÿ‡ธ USA

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.